Wendy Wilson-Lee, Ph.D.
Acting Branch Chief
Office of New Drug Products
Center for Drug Evaluation and Research
Federal Drug Administration
Wendy Wilson-Lee, Ph.D. is an Acting Branch Chief in the Office of New Drug Products (ONDP), within CDER’s Office of Pharmaceutical Quality (OPQ). She joined FDA in September 2006, after working as a formulation scientist in the pharmaceutical industry.
Wendy earned her Doctorate in Pharmaceutical Science at the University of Maryland – Baltimore under Dr. Larry Augsburger. She holds dual Bachelor of Science degrees in Chemical Engineering and Chemistry from North Carolina A&T State University. In addition to her academic honors, Wendy also is a graduate of the Excellence in Government Leadership Program.
Dr. Wilson-Lee is currently using her new role as Acting Branch Chief to help shape the culture and review operations of ONDP and OPQ. She is the project lead for ONDP’s Product Quality Benefit Risk Framework and has given several presentations on linking product quality to patient outcomes. Wendy is a wife and a mother and enjoys sharing her love of S.T.E.A.M and leadership development as a speaker and coach for elementary, middle, and high school girls.